CNO Financial Group Announces Voting Results from 2025 Annual Meeting of Shareholders
CNO Financial Group (NYSE: CNO) held its 2025 Annual Meeting of Shareholders with several key agenda items approved. Shareholders elected nine directors to serve one-year terms and approved the executive compensation package through a non-binding advisory vote. The meeting also resulted in the ratification of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for 2025.
Additionally, shareholders approved three significant amendments: the Amended and Restated Certificate of Incorporation including the Replacement NOL Protective Amendment to preserve tax benefits, the Amended and Restated Long-Term Incentive Plan, and the Amended and Restated Employee Stock Purchase Plan.
CNO Financial Group (NYSE: CNO) ha tenuto la sua Assemblea Annuale degli Azionisti del 2025, durante la quale sono stati approvati diversi punti chiave all'ordine del giorno. Gli azionisti hanno eletto nove amministratori per un mandato di un anno e hanno approvato il pacchetto di compensi esecutivi tramite un voto consultivo non vincolante. La riunione ha inoltre portato alla ratifica di PricewaterhouseCoopers LLP come società di revisione contabile indipendente per il 2025.
Inoltre, gli azionisti hanno approvato tre importanti modifiche: il Certificato di Incorporazione Modificato e Ristabilito, inclusa l'Emendamento Protettivo NOL di Sostituzione per preservare i benefici fiscali, il Piano Incentivi a Lungo Termine Modificato e Ristabilito, e il Piano di Acquisto Azioni per i Dipendenti Modificato e Ristabilito.
CNO Financial Group (NYSE: CNO) celebró su Junta Anual de Accionistas 2025, en la que se aprobaron varios puntos clave del orden del día. Los accionistas eligieron a nueve directores para un mandato de un año y aprobaron el paquete de compensación ejecutiva mediante una votación consultiva no vinculante. La reunión también resultó en la ratificación de PricewaterhouseCoopers LLP como la firma independiente de auditoría registrada de la compañía para 2025.
Además, los accionistas aprobaron tres enmiendas importantes: el Certificado de Incorporación Modificado y Restablecido, que incluye la Enmienda Protectora de NOL de Reemplazo para preservar beneficios fiscales, el Plan de Incentivos a Largo Plazo Modificado y Restablecido, y el Plan de Compra de Acciones para Empleados Modificado y Restablecido.
CNO Financial Group (NYSE: CNO)는 2025년 연례 주주총회를 개최하여 여러 주요 안건을 승인했습니다. 주주들은 9명의 이사를 1년 임기로 선출했으며, 경영진 보상 패키지를 비구속적 자문 투표를 통해 승인했습니다. 또한 이번 회의에서는 2025년 회사의 독립 등록 공인 회계 법인으로 PricewaterhouseCoopers LLP를 재선임하는 안건도 통과되었습니다.
추가로 주주들은 세 가지 중요한 수정안을 승인했습니다: 세금 혜택을 보존하기 위한 대체 NOL 보호 수정안이 포함된 수정 및 재작성된 정관, 수정 및 재작성된 장기 인센티브 계획, 그리고 수정 및 재작성된 직원 주식 구매 계획입니다.
CNO Financial Group (NYSE : CNO) a tenu son Assemblée Annuelle des Actionnaires 2025, au cours de laquelle plusieurs points clés à l'ordre du jour ont été approuvés. Les actionnaires ont élu neuf administrateurs pour un mandat d'un an et ont approuvé le package de rémunération des dirigeants par un vote consultatif non contraignant. La réunion a également abouti à la ratification de PricewaterhouseCoopers LLP en tant que cabinet comptable indépendant enregistré de la société pour 2025.
De plus, les actionnaires ont approuvé trois modifications importantes : le certificat de constitution modifié et révisé incluant l'amendement de protection NOL de remplacement pour préserver les avantages fiscaux, le plan d'incitation à long terme modifié et révisé, ainsi que le plan d'achat d'actions des employés modifié et révisé.
CNO Financial Group (NYSE: CNO) hielt seine Hauptversammlung 2025 ab, bei der mehrere wichtige Tagesordnungspunkte genehmigt wurden. Die Aktionäre wählten neun Direktoren für eine einjährige Amtszeit und genehmigten das Vergütungspaket für Führungskräfte durch eine unverbindliche Beratungsabstimmung. Außerdem wurde PricewaterhouseCoopers LLP als unabhängige eingetragene Wirtschaftsprüfungsgesellschaft für das Jahr 2025 bestätigt.
Darüber hinaus stimmten die Aktionäre drei bedeutenden Änderungen zu: der geänderten und neu gefassten Satzung einschließlich des Ersatz-NOL-Schutzantrags zur Erhaltung steuerlicher Vorteile, dem geänderten und neu gefassten langfristigen Anreizplan sowie dem geänderten und neu gefassten Mitarbeiteraktienkaufplan.
- None.
- None.
- Elected nine directors (Gary C. Bhojwani, Archie M. Brown, David B. Foss, Mary R. (Nina) Henderson, Adrianne B. Lee, Daniel R. Maurer, Chetlur S. Ragavan, Steven E. Shebik, and Jessica A. Turner) to each serve a one-year term expiring at next year's annual meeting.
- Approved, by non-binding advisory vote, the executive compensation of the company's named executive officers as disclosed in the proxy statement for the annual meeting.
- Ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for 2025.
- Approved the company's Amended and Restated Certificate of Incorporation to include the Replacement NOL Protective Amendment to preserve the value of tax net operating losses and certain other tax losses.
- Approved the company's Amended and Restated Long-Term Incentive Plan.
- Approved the company's Amended and Restated Employee Stock Purchase Plan.
About CNO Financial Group
CNO Financial Group, Inc. (NYSE: CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services, and workforce benefits solutions through our family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. Our customers work hard to save for the future, and we help protect their health, income and retirement needs with 3.2 million policies and
View original content to download multimedia:https://www.prnewswire.com/news-releases/cno-financial-group-announces-voting-results-from-2025-annual-meeting-of-shareholders-302450434.html
SOURCE CNO Financial Group
FAQ
What were the key decisions made at CNO Financial Group's 2025 Annual Meeting?
Who are the directors elected to CNO Financial Group's board in 2025?
What is the purpose of CNO's NOL Protective Amendment approved in 2025?
Which accounting firm was approved as CNO Financial Group's auditor for 2025?
